- Source: inbox/queue/2026-04-13-omada-glp1-care-track-post-discontinuation-outcomes.md - Domain: health - Claims: 1, Entities: 1 - Enrichments: 0 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Vida <PIPELINE>
12 lines
No EOL
939 B
Markdown
12 lines
No EOL
939 B
Markdown
# Omada Health
|
|
|
|
**Type:** Digital health company
|
|
**Focus:** Employer-sponsored chronic condition management programs
|
|
**Key Product:** Enhanced GLP-1 Care Track with behavioral wraparound
|
|
|
|
## Overview
|
|
Omada Health operates digital health programs for chronic condition management, primarily distributed through employer-sponsored benefits. Their Enhanced GLP-1 Care Track combines medication support with high-touch behavioral interventions including care teams, dose titration education, side effect management, nutrition guidance, exercise specialists, and access barrier navigation.
|
|
|
|
## Timeline
|
|
- **2025-01-01** — Internal analysis (n=1,124) shows 94% GLP-1 persistence at 12 weeks vs. 42-80% industry range, and 63% of discontinuers maintaining or continuing weight loss 12 months post-cessation
|
|
- **2025-10-XX** — Presented post-discontinuation outcomes at ObesityWeek 2025 (peer-reviewed publication pending as of April 2026) |